Skip to content
Blackberry Empire – Lifestyle
Author:
Protagonist Therapeutics
Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasis
March 18, 2026
←
Previous Page
1
2